Theratechnologies (TH) Stock Price, News & Analysis

Company Overview

Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States.

Key Stats

• Today's Range: C$4.36 to C$4.53
• 50-Day Range: C$4.47 to C$4.47
• 52-Week Range: C$1.59 to C$4.73
• Volume: 35,472 shs
• Average Volume: 75,081 shs
• Market Capitalization: C$205.53 million
• P/E Ratio: N/A
• Dividend Yield: 3.76%
• Price Target: N/A
• Consensus Rating: Hold

Industry, Sector and Symbol

• Stock Exchange: TSE
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: Restaurants, Hotels, Motels
• Current Symbol: TSE:TH
• CIK: N/A
• Web: www.theratech.com
• Phone: +1-514-3367800
• Fax: N/A
• Employees: 103
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): C($0.19)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 149.68
• P/E Growth: -8.5
• Net Income: -C$1.96 million
• Net Margins: -11.81%
• Pretax Margin: N/A
• Return on Equity: 16.59%
• Return on Assets: 5.15%

Debt

• Debt-to-Equity Ratio: -156.22
• Current Ratio: 0.84
• Quick Ratio: 0.64

Sales & Book Value

• Annual Sales: C$84.38 million
• Price / Sales: 2.44
• Cash Flow: C$1.19 per share
• Price / Cash Flow: 3.76
• Book Value: C($0.57) per share
• Price / Book: -7.90

Miscellaneous

• Outstanding Shares: 45,980,000
• Free Float: N/A
• Market Cap: C$205.53 million
• Optionable: Not Optionable
• Beta: 0.26